PT893999E - Processo para a producao para a producao de preparacoes de cloridrato de efonidipina - Google Patents
Processo para a producao para a producao de preparacoes de cloridrato de efonidipinaInfo
- Publication number
- PT893999E PT893999E PT97907336T PT97907336T PT893999E PT 893999 E PT893999 E PT 893999E PT 97907336 T PT97907336 T PT 97907336T PT 97907336 T PT97907336 T PT 97907336T PT 893999 E PT893999 E PT 893999E
- Authority
- PT
- Portugal
- Prior art keywords
- treatment
- production
- efonidipine
- mixture
- water
- Prior art date
Links
- NSVFSAJIGAJDMR-UHFFFAOYSA-N 2-[benzyl(phenyl)amino]ethyl 5-(5,5-dimethyl-2-oxido-1,3,2-dioxaphosphinan-2-yl)-2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3-carboxylate Chemical compound CC=1NC(C)=C(C(=O)OCCN(CC=2C=CC=CC=2)C=2C=CC=CC=2)C(C=2C=C(C=CC=2)[N+]([O-])=O)C=1P1(=O)OCC(C)(C)CO1 NSVFSAJIGAJDMR-UHFFFAOYSA-N 0.000 title abstract 4
- 229950003102 efonidipine Drugs 0.000 title abstract 4
- 238000004519 manufacturing process Methods 0.000 title abstract 3
- 238000002360 preparation method Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 abstract 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 3
- 238000010438 heat treatment Methods 0.000 abstract 2
- 230000000968 intestinal effect Effects 0.000 abstract 2
- 239000007962 solid dispersion Substances 0.000 abstract 2
- 238000007598 dipping method Methods 0.000 abstract 1
- 229920000639 hydroxypropylmethylcellulose acetate succinate Polymers 0.000 abstract 1
- 238000005470 impregnation Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000003960 organic solvent Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
Landscapes
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Hydrogenated Pyridines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP8886996 | 1996-03-18 | ||
| JP8886896 | 1996-03-18 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT893999E true PT893999E (pt) | 2002-12-31 |
Family
ID=26430207
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT97907336T PT893999E (pt) | 1996-03-18 | 1997-03-17 | Processo para a producao para a producao de preparacoes de cloridrato de efonidipina |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US6171599B1 (pt) |
| EP (1) | EP0893999B8 (pt) |
| KR (1) | KR100457273B1 (pt) |
| AT (1) | ATE223722T1 (pt) |
| AU (1) | AU1941897A (pt) |
| CA (1) | CA2248582C (pt) |
| DE (1) | DE69715395T2 (pt) |
| ES (1) | ES2184063T3 (pt) |
| PT (1) | PT893999E (pt) |
| TW (1) | TW487574B (pt) |
| WO (1) | WO1997034610A1 (pt) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE364374T1 (de) | 1997-08-11 | 2007-07-15 | Pfizer Prod Inc | Feste pharmazeutische dispersionen mit erhöhter bioverfügbarkeit |
| IL161134A0 (en) * | 2002-02-28 | 2004-08-31 | Japan Tobacco Inc | Ester compound and medical use thereof |
| EP1669345A4 (en) * | 2003-08-29 | 2008-02-20 | Japan Tobacco Inc | ESTER DERIVATIVE AND MEDICAL USE THEREOF |
| US20060030623A1 (en) * | 2004-07-16 | 2006-02-09 | Noboru Furukawa | Agent for the treatment or prevention of diabetes, obesity or arteriosclerosis |
| DE602005018387D1 (de) * | 2004-10-06 | 2010-01-28 | Eisai R&D Man Co Ltd | Medizinische zusammensetzung, verfahren zu ihrer hdihydropyridin-verbindung in einer medizinischen zusammensetzung |
| US8101774B2 (en) * | 2004-10-18 | 2012-01-24 | Japan Tobacco Inc. | Ester derivatives and medicinal use thereof |
| KR20070072888A (ko) * | 2004-10-25 | 2007-07-06 | 니뽄 다바코 산교 가부시키가이샤 | 용해성 및 안정성이 개선된 고형 제제 및 그의 제조 방법 |
| JP5103173B2 (ja) * | 2005-04-28 | 2012-12-19 | エルメッド エーザイ株式会社 | ジヒドロピリジン系化合物の分解を防止する方法 |
| WO2007108463A1 (ja) | 2006-03-23 | 2007-09-27 | Shionogi & Co., Ltd. | 溶解性が改善された固形製剤 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1016063B (zh) | 1986-01-22 | 1992-04-01 | 日产化学工业株式会社 | 二氢吡啶-5-膦酸环亚丙基酯的制备 |
| JP2528706B2 (ja) | 1988-05-30 | 1996-08-28 | ゼリア新薬工業株式会社 | ジヒドロピリジン化合物の製剤組成物 |
-
1997
- 1997-03-17 AT AT97907336T patent/ATE223722T1/de not_active IP Right Cessation
- 1997-03-17 KR KR10-1998-0707339A patent/KR100457273B1/ko not_active Expired - Fee Related
- 1997-03-17 PT PT97907336T patent/PT893999E/pt unknown
- 1997-03-17 EP EP97907336A patent/EP0893999B8/en not_active Expired - Lifetime
- 1997-03-17 AU AU19418/97A patent/AU1941897A/en not_active Abandoned
- 1997-03-17 DE DE69715395T patent/DE69715395T2/de not_active Expired - Fee Related
- 1997-03-17 WO PCT/JP1997/000842 patent/WO1997034610A1/en not_active Ceased
- 1997-03-17 TW TW086103291A patent/TW487574B/zh not_active IP Right Cessation
- 1997-03-17 US US09/142,208 patent/US6171599B1/en not_active Expired - Fee Related
- 1997-03-17 ES ES97907336T patent/ES2184063T3/es not_active Expired - Lifetime
- 1997-03-17 CA CA002248582A patent/CA2248582C/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| DE69715395T2 (de) | 2003-05-15 |
| WO1997034610A1 (en) | 1997-09-25 |
| EP0893999B1 (en) | 2002-09-11 |
| DE69715395D1 (de) | 2002-10-17 |
| ATE223722T1 (de) | 2002-09-15 |
| AU1941897A (en) | 1997-10-10 |
| KR100457273B1 (ko) | 2005-04-08 |
| EP0893999A1 (en) | 1999-02-03 |
| CA2248582A1 (en) | 1997-09-25 |
| EP0893999B8 (en) | 2003-01-02 |
| CA2248582C (en) | 2005-06-14 |
| US6171599B1 (en) | 2001-01-09 |
| TW487574B (en) | 2002-05-21 |
| ES2184063T3 (es) | 2003-04-01 |
| KR20000064632A (ko) | 2000-11-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT893999E (pt) | Processo para a producao para a producao de preparacoes de cloridrato de efonidipina | |
| DE69600622D1 (de) | Bilden von lösungen von cellulose in wässrigem tertiärem aminoxid | |
| NO151504C (no) | Fremgangsmaate ved toerking og brenning av vannholdige, faste brensler | |
| NO971303D0 (no) | Fremgangsmåte for fremstilling av vaske- og rengjöringsmiddel-tabletter ved hjelp av mikrobölge- og varmluftbehandling | |
| FR2429210B1 (pt) | ||
| BR9100863A (pt) | Processo para a preparacao de massas alimenticias secas | |
| ATE198791T1 (de) | Behandlung eines wasserhaltigen brennstoffs | |
| KR950024707A (ko) | 홍삼제조방법 | |
| BR0009004A (pt) | Dispositivo e processo para o tratamento dematerial sintético | |
| AU4761800A (en) | Method and apparatus for burning materials with low combustibility | |
| IT1277425B1 (it) | Metodo per la preparazione della 1-b-d-arabinofuranosilcitosina | |
| KR900004274A (ko) | 인삼에서 엑기스를 추출하는 방법 | |
| SU1011643A1 (ru) | Способ получени 1-метил-5-амино-4-нитроимидазола | |
| RU95104068A (ru) | Способ сушки растворенных или суспендированных веществ | |
| SU947252A1 (ru) | Способ изготовлени бумажного диэлектрика | |
| SU1150263A1 (ru) | Способ очистки биомассы дрожжей | |
| KR940006640A (ko) | 사문석을 주제로한 흡착제 제조방법 | |
| ATE441332T1 (de) | Ozonbehandlung von lignocellulose substraten | |
| KR900001321A (ko) | 건(乾) 만두속의 여열량(餘熱量)을 이용한 만두 진공건조방법 | |
| GB2000146A (en) | Stabilisation of nitrocellulose after pressure boiling | |
| KR920010708A (ko) | 형광표시관의 에이징방법 | |
| NO922847L (no) | Fremgangsmaate ved lesking av ulesket kalk i aske | |
| SE9804024L (sv) | Förfarande för behandling av svartlut | |
| KR950016601A (ko) | 불활성 기체를 사용한 잎담배 팽화방법 | |
| JPS52152650A (en) | Apparatus for treating organic sludge |